The efficacy of epirubicin, cisplatin, uracil/tegafur, and leucovorin in patients with advanced biliary tract carcinoma.

@article{Park2005TheEO,
  title={The efficacy of epirubicin, cisplatin, uracil/tegafur, and leucovorin in patients with advanced biliary tract carcinoma.},
  author={K Y Park and I Choi and Seok-Jin Kim and Sang-Chul Oh and Jae-Hong Seo and Chul-Won Choi and Byung-soo Kim and Sang-Won Shin and Yeul Hong Kim and Jun-Suk Kim},
  journal={Cancer},
  year={2005},
  volume={103 11},
  pages={2338-43}
}
BACKGROUND Advanced biliary tract carcinoma is among the most prevalent fatal diseases in Korea. However, to our knowledge, to date no effective therapeutic modality has been shown to prolong the survival of patients in the inoperable stages of this disease. METHODS This Phase II study was conducted to determine the efficacy and toxicity of a combined… CONTINUE READING